Shreeram Aradhye

EVP &Chief Development Officer, Axcella Health (United States).

Companies

Dicerna Pharmaceuticals (United States)EVP & Chief Medical Officer Sep 9, 2020 to Dec 29, 2021¹
Axcella Health (United States)Board member Sep 3, 2020 to May 24, 2021²
Axcella Health (United States)EVP &Chief Development Officer May 31, 2019 to Dec 20, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dicerna Pharmaceuticals (United States)0 shares⁴Dec 28, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 28, 2021U 6,973 shares at $38.25 of Dicerna Pharmaceuticals (United States)⁴
Dec 15, 2021Shares withheld for tax 833 shares at $38.05 of Dicerna Pharmaceuticals (United States)⁵
Dec 15, 2021Exercised options 2,837 shares of Dicerna Pharmaceuticals (United States)⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDicerna Pharmaceuticals (United States), EVP & Chief Medical Officer
2
SEC EDGARAxcella Health (United States), Board member
3
SEC EDGARAxcella Health (United States), EVP &Chief Development Officer
4
SEC EDGARDicerna Pharmaceuticals (United States) shares after the filing of Dec 28, 2021
5
SEC EDGARForm 4 filed Dec 17, 2021